OnCore Login

Return to Trial Database

BTCRC-GI22-588

A Phase II Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

Status

Currently Enrolling

Cancer Type(s)

Anal

Study Contact

(317) 921-2050
studies@hoosiercancer.org

Trial Locations

All sites in which the trial BTCRC-GI22-588 being conducted in.
Rutgers Cancer Institute of New Jersey
University of Wisconsin Carbone Cancer Center
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278